Sign Up Today and Learn More About Malwarebytes Stock
Invest in or calculate the value of your shares in Malwarebytes or other pre-IPO companies through EquityZen's platform.
Malwarebytes Stock (MALW)
Cybersecurity Company
Malwarebytes provides consumers and organizations with device protection, privacy, and prevention.
About Malwarebytes Stock
Founded
2008
Headquarters
Santa Clara, CA, US
Total Funding
180M
Industries
Travel and Tourism, Space, Transportation
Malwarebytes claims to provide consumers and organizations with device protection, privacy, and prevention through their solutions in the home, on the go, at work, or on campus. Malwarebyte claims to offer protection from threats such as malware, ransomware, and exploits that could escape detection through traditional antivirus solutions.Â
Malwarebytes was founded in 2008 and is headquartered in Santa Clara, CA. Notable investors include Highland Capital Partners and Fidelity.
Malwarebytes Press Mentions
Stay in the know about the latest news on Malwarebytes
Android Mobile Adware Surges in Second Half of 2025
prnewswire • Dec 17, 2025
Malwarebytes Launches New Enhanced Mac Scan Engine for Smarter, Deeper macOS Threat Protection
prnewswire • Dec 11, 2025
New Malwarebytes Research Reveals Social Media and Marketplaces Are Hotbeds for Holiday Scams
prnewswire • Nov 20, 2025
ThreatDown Launches Nexus Partner Program, Strengthening its Channel-First Commitment
businesswire • Nov 12, 2025
Malwarebytes for Teams
au • Nov 09, 2025
Investors in Malwarebytes
Discover investors in Malwarebytes stock and explore their portfolio companies
Malwarebytes Management
Leadership team at Malwarebytes
Chief Executive Officer
Marcin Kleczynski
President & Chief Financial Officer
Tom Fox
Join now and verify your accreditation status to gain access to:
- Malwarebytes Current Valuation
- Malwarebytes Stock Price
- Malwarebytes Management
- Available deals in Malwarebytes and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Malwarebytes Cap Table and Funding History by Share Class and Liquidity Preferences
- Malwarebytes Revenue and Financials
- Malwarebytes Highlights
- Malwarebytes Business Model
- Malwarebytes Risk Factors
- Malwarebytes Research Report from SACRA Research
Malwarebytes Key Facts
- Strategic Expansion into Integrated Managed Security: In late 2025, Malwarebytes leveraged its corporate business unit, ThreatDown, to aggressively expand into the Managed Detection and Response (MDR) market. A pivotal strategic initiative was the July 2025 launch of ThreatDown Email Security in partnership with Ironscales. This AI-powered module integrates real-time phishing protection directly into the Nebula and OneView consoles, allowing IT teams to manage both endpoint and email threats from a single interface. This consolidation addresses a major pain point for Small and Mid-sized Businesses (SMBs) and Managed Service Providers (MSPs), significantly increasing Malwarebytes' enterprise market share by reducing operational complexity.
- Dominance in Mobile and Multi-Platform Protection: Throughout 2025, Malwarebytes demonstrated strong technical efficacy in the rapidly growing mobile threat sector. Its Mobile Security solution achieved near-perfect detection rates, earning its seventh consecutive MRG Effitas Android 360° Certification in November 2025. Furthermore, the company was the only provider to achieve a 100% detection rate in the September 2025 AV-Comparatives Stalkerware Test. These results, combined with the launch of "Scam Guard" and advanced text filtering, have cemented Malwarebytes as the leading choice for users seeking protection on non-Windows platforms, particularly as mobile adware and banking Trojans surged in the latter half of 2025.
- Consumer Brand Leadership and Ecosystem Partnerships: Malwarebytes enters 2026 with a strong brand reputation, as evidenced by topping three categories in the 2025 PCMag Readers' Choice Awards (Best PC Security Suite, Best Android, and Best iOS/iPadOS Antivirus). The company’s growth is further bolstered by a robust "white-label" and strategic partnership strategy. Integration with major telcos and ISPs, such as eero Plus and Yahoo, has expanded its reach to millions of users who benefit from bundled Malwarebytes Premium protection. This high consumer trust may act as a competitive moat against built-in tools like Microsoft Defender, which saw rising "passive acceptance" among general users in 2025.
- Execution Risk from Strategic Split and Personnel Churn: The ongoing reorganization to split Malwarebytes into separate consumer and enterprise businesses (ThreatDown) has introduced material operational risk. Following a 13% workforce reduction (approx. 110 employees) and a "C-suite exodus" involving the CIO, CTO, and Chief Product Officer, the company faces a period of high internal volatility. This "brain drain" threatens to slow the development of AI-driven proactive features at a time when adversaries are deploying agentic AI and modular malware that bypass traditional signature-based detection, potentially leaving Malwarebytes' product roadmap behind more agile, AI-native competitors like SentinelOne.
- Unclear funding trajectory and private‑market pressure: Public information on Malwarebytes’ primary funding is dated (with a reported $80 million over two rounds and the last major raise in 2016). In a cybersecurity market where many peers have raised substantial late‑stage rounds or gone public to fund AI, XDR, and cloud‑security expansion, this may constrain Malwarebytes’ ability to invest at the pace of better‑funded rivals, raising medium‑term risk around product breadth, go‑to‑market intensity, and potential dilution or down‑round dynamics if growth slows.Â
Trading Malwarebytes Stock
How to invest in Malwarebytes stock?
Accredited investors can buy pre-IPO stock in companies like Malwarebytes through EquityZen funds. These investments are made available by existing Malwarebytes shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Malwarebytes stock?
Shareholders can sell their Malwarebytes stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
